We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ceres Plans IPO; leader in biofuel genomics
News

Ceres Plans IPO; leader in biofuel genomics

Ceres Plans IPO; leader in biofuel genomics
News

Ceres Plans IPO; leader in biofuel genomics

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ceres Plans IPO; leader in biofuel genomics"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ceres Plans IPO to Challenge Monsanto in Modified Seeds

May 23, 2011, 6:16 PM EDT


By Jack Kaskey of Bloomberg

 May 23 (Bloomberg) -- Ceres Inc., a U.S. seed maker, plans to raise as much as $100 million in an initial public offering to expand output of genetically modified crops used in the production of biofuels

The shares will be listed on the Nasdaq Stock Market under the symbol CERE, the Thousand Oaks, California-based company said today in a filing with the U.S. Securities and Exchange Commission. Ceres, which has been operating since 1997, will use some of the proceeds from the IPO to develop, produce and commercialize crop seeds

Goldman Sachs Group Inc. and Barclays Plc will underwrite the IPO, according to the filing. Ceres didn’t say how many shares would be sold, or provide a price range.

Ceres is ramping up production to challenge Monsanto and DuPont Co.’s Pioneer unit, the two largest makers of genetically modified crops. Ceres has commercialized sweet sorghum that serves as an alternative to sugarcane in the Brazilian ethanol industry. It’s developing other so-called energy crops as well as plants that tolerate drought and salt.

Monsanto has been working with Ceres to develop improved corn and soybeans. Ceres said in the filing that St. Louis-based Monsanto has a license to some of its genetic traits. Monsanto has a 6.4 percent stake in Ceres.

Other Ceres investors include Artal Luxembourg SA with an 18 percent stake; Warburg Pincus Private Equity IX LP with 16 percent; Ambergate Trust with 14 percent; and Oxford Bioscience with 11 percent.

--Editors: Simon Casey, Niamh Ring

Advertisement